A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

Clinical trial NCT06962800 · RECRUITING

Trial details

NCT number: NCT06962800
Sponsor: Biogen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Membranous Nephropathy

Start date: 2025-05-22
Primary completion: 2030-01-28
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.